Security key
928661107
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)
CUSIP: 928661107
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 159,533,673
- Total 13F shares
- 26,125,378
- Share change
- +2,140,218
- Total reported value
- $17,729,734
- Price per share
- $0.68
- Number of holders
- 32
- Value change
- +$1,443,851
- Number of buys
- 20
- Number of sells
- 6
Report period
Q3 2025
Institutions
32
Top holders
10
VNRX full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
VOLITIONRX LTD SEC filings
VOLITIONRX LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 928661107
Recent filing periods:
Top shareholders of VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. |
13F
|
Company |
7.3%
|
11,705,000
|
$8,895,800 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
5.3%
|
8,493,074
|
$6,454,736 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
1,624,731
|
$1,234,796 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
764,891
|
$581,437 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.28%
|
445,187
|
$338,342 | — | 30 Jun 2025 | |
| Silverberg Bernstein Capital Management LLC |
13F
|
Company |
0.13%
|
200,782
|
$152,594 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
193,745
|
$147,246 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
147,638
|
$112,205 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
117,875
|
$89,585 | — | 30 Jun 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.04%
|
68,570
|
$52,113 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
58,195
|
$44,228 | — | 30 Jun 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.03%
|
40,000
|
$30,400 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
30,596
|
$23,253 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
20,500
|
$15,580 | — | 30 Jun 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.01%
|
17,713
|
$13,019 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
16,668
|
$12,668 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
11,993
|
$9,000 | — | 30 Jun 2025 | |
| Creative Planning |
13F
|
Company |
0.01%
|
10,056
|
$7,643 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
5,288
|
$4,019 | — | 30 Jun 2025 | |
| Ameritas Advisory Services, LLC |
13F
|
Company |
0%
|
4,000
|
$3,040 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
3,000
|
$2,000 | — | 30 Jun 2025 | |
| Founders Capital Management |
13F
|
Company |
0%
|
2,000
|
$1,520 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,377
|
$1,047 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
910
|
$692 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
800
|
$608 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
265
|
$201 | — | 30 Jun 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
200
|
$152 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
106
|
$81 | — | 30 Jun 2025 | |
| Eight Corp Ltd |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
24,030,664
mixed-class rows
|
$20,785,825 | — | 02 Jan 2024 | |
| Martin Charles Faulkes |
3/4/5
|
Executive Director, Director |
—
class O/S missing
|
2,096,207
|
$1,739,852 | — | 24 Jan 2024 | |
| Edward Futcher |
3/4/5
|
Director |
—
class O/S missing
|
436,436
|
$362,242 | — | 24 Jan 2024 | |
| Jason Bradley Terrell MD |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
33,192
|
$27,550 | — | 03 Aug 2022 | |
| Richard Brudnick |
3/4/5
|
Director |
—
class O/S missing
|
27,936
|
$23,187 | — | 12 Jan 2023 |
Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2025
As of 30 Sep 2025,
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,125,378 shares.
The largest 10 holders included
Lagoda Investment Management, L.P., ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., CITADEL ADVISORS LLC, STATE STREET CORP, Silverberg Bernstein Capital Management LLC, NORTHERN TRUST CORP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
28
Q3 2025 holders
32
Holder diff
4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.